POST ACUTE SEQUELAE OF COVID-19
Clinical trials for POST ACUTE SEQUELAE OF COVID-19 explained in plain language.
Never miss a new study
Get alerted when new POST ACUTE SEQUELAE OF COVID-19 trials appear
Sign up with your email to follow new studies for POST ACUTE SEQUELAE OF COVID-19, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could an antiviral pill ease long COVID?
Disease control OngoingThis study tests whether the antiviral drug ensitrelvir can help people with Long COVID by clearing leftover virus from the body. About 40 adults with persistent symptoms will receive either the drug or a placebo. The main goal is to see if the drug improves physical health and r…
Matched conditions: POST ACUTE SEQUELAE OF COVID-19
Phase: PHASE2 • Sponsor: Timothy Henrich • Aim: Disease control
Last updated Jun 16, 2026 12:52 UTC
-
New drug trial aims to ease long COVID symptoms in kids and adults
Disease control OngoingThis study tests whether the drug larazotide can safely reduce Long COVID symptoms in people aged 7 to 50. Participants take the drug or a placebo four times daily for 21 days. The goal is to see if symptoms like fatigue, brain fog, and breathing problems improve. The trial is no…
Matched conditions: POST ACUTE SEQUELAE OF COVID-19
Phase: PHASE2 • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated Jun 02, 2026 11:59 UTC
-
At-Home brain zaps show promise for long COVID fog
Symptom relief OngoingThis study tested whether a noninvasive brain stimulation technique called tDCS, done at home, could improve thinking problems like brain fog in 31 people with long COVID. Participants used a headset that delivered mild electrical currents to the brain for 4 weeks. The goal was t…
Matched conditions: POST ACUTE SEQUELAE OF COVID-19
Phase: NA • Sponsor: Massachusetts General Hospital • Aim: Symptom relief
Last updated Jun 15, 2026 19:06 UTC
-
New test aims to forecast COVID-19 Patients' future health
Knowledge-focused OngoingThis study aims to create a test that can predict how well hospitalized COVID-19 patients will recover in the short and long term (up to one year). Researchers will collect medical information and blood samples from 600 adults across the U.S. to identify who is at risk for ongoin…
Matched conditions: POST ACUTE SEQUELAE OF COVID-19
Sponsor: University of California, Los Angeles • Aim: Knowledge-focused
Last updated Jun 12, 2026 12:08 UTC